Report Detail
Global Tuberculosis Vaccine Treatment Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
- RnM3869331 |
- 26 September, 2024 |
- Global |
- 125 Pages |
- GIR (Global Info Research) |
- Other
Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.
Besides, BCG Vaccine is also used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive.
According to our (Global Info Research) latest study, the global Tuberculosis Vaccine Treatment market size was valued at US$ 78.5 million in 2023 and is forecast to a readjusted size of USD 95.3 million by 2030 with a CAGR of 2.8% during review period.
In the last several years, global market of Tuberculosis Vaccine Treatment developed smoothly, with an average growth rate of 0.73%.
The classification of Tuberculosis Vaccine Treatment includes Immune Vaccine and Therapy Vaccine, and the proportion of Immune Vaccine in 2019 is about 99.66%.
Tuberculosis Vaccine Treatment is widely sold through Self-Procurement, UNICEF and Other. The most proportion of Tuberculosis Vaccine Treatment is sold through Self-Procurement, and the proportion in 2019 is 62.14%.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 45% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of 35.66%.
Market competition is intense. Merck, Japan BCG Lab, Serum Institute of India are the leaders of the industry, they occupy the 60% of the market.
This report is a detailed and comprehensive analysis for global Tuberculosis Vaccine Treatment market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Tuberculosis Vaccine Treatment market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (USD/K Dose), 2019-2030
Global Tuberculosis Vaccine Treatment market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (USD/K Dose), 2019-2030
Global Tuberculosis Vaccine Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (USD/K Dose), 2019-2030
Global Tuberculosis Vaccine Treatment market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (USD/K Dose), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Tuberculosis Vaccine Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Tuberculosis Vaccine Treatment market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, Biomed Lublin, Taj Pharmaceuticals, Ataulpho de Paiva, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Tuberculosis Vaccine Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Immune Vaccine
Therapy Vaccine
Market segment by Application
Self-Procurement
UNICEF
Other
Major players covered
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC
Queen Saovabha Mem. Inst
Microgen
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tuberculosis Vaccine Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Tuberculosis Vaccine Treatment, with price, sales quantity, revenue, and global market share of Tuberculosis Vaccine Treatment from 2019 to 2024.
Chapter 3, the Tuberculosis Vaccine Treatment competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tuberculosis Vaccine Treatment breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Tuberculosis Vaccine Treatment market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Tuberculosis Vaccine Treatment.
Chapter 14 and 15, to describe Tuberculosis Vaccine Treatment sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Tuberculosis Vaccine Treatment Consumption Value by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Immune Vaccine
- 1.3.3 Therapy Vaccine
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Tuberculosis Vaccine Treatment Consumption Value by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Self-Procurement
- 1.4.3 UNICEF
- 1.4.4 Other
- 1.5 Global Tuberculosis Vaccine Treatment Market Size & Forecast
- 1.5.1 Global Tuberculosis Vaccine Treatment Consumption Value (2019 & 2023 & 2030)
- 1.5.2 Global Tuberculosis Vaccine Treatment Sales Quantity (2019-2030)
- 1.5.3 Global Tuberculosis Vaccine Treatment Average Price (2019-2030)
2 Manufacturers Profiles
- 2.1 Merck
- 2.1.1 Merck Details
- 2.1.2 Merck Major Business
- 2.1.3 Merck Tuberculosis Vaccine Treatment Product and Services
- 2.1.4 Merck Tuberculosis Vaccine Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Merck Recent Developments/Updates
- 2.2 Japan BCG Lab
- 2.2.1 Japan BCG Lab Details
- 2.2.2 Japan BCG Lab Major Business
- 2.2.3 Japan BCG Lab Tuberculosis Vaccine Treatment Product and Services
- 2.2.4 Japan BCG Lab Tuberculosis Vaccine Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Japan BCG Lab Recent Developments/Updates
- 2.3 Serum Institute of India
- 2.3.1 Serum Institute of India Details
- 2.3.2 Serum Institute of India Major Business
- 2.3.3 Serum Institute of India Tuberculosis Vaccine Treatment Product and Services
- 2.3.4 Serum Institute of India Tuberculosis Vaccine Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Serum Institute of India Recent Developments/Updates
- 2.4 AJ Vaccines
- 2.4.1 AJ Vaccines Details
- 2.4.2 AJ Vaccines Major Business
- 2.4.3 AJ Vaccines Tuberculosis Vaccine Treatment Product and Services
- 2.4.4 AJ Vaccines Tuberculosis Vaccine Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 AJ Vaccines Recent Developments/Updates
- 2.5 BioFarma
- 2.5.1 BioFarma Details
- 2.5.2 BioFarma Major Business
- 2.5.3 BioFarma Tuberculosis Vaccine Treatment Product and Services
- 2.5.4 BioFarma Tuberculosis Vaccine Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 BioFarma Recent Developments/Updates
- 2.6 GreenSignal Bio Pharma
- 2.6.1 GreenSignal Bio Pharma Details
- 2.6.2 GreenSignal Bio Pharma Major Business
- 2.6.3 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product and Services
- 2.6.4 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 GreenSignal Bio Pharma Recent Developments/Updates
- 2.7 China National Biotec
- 2.7.1 China National Biotec Details
- 2.7.2 China National Biotec Major Business
- 2.7.3 China National Biotec Tuberculosis Vaccine Treatment Product and Services
- 2.7.4 China National Biotec Tuberculosis Vaccine Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.7.5 China National Biotec Recent Developments/Updates
- 2.8 Biomed Lublin
- 2.8.1 Biomed Lublin Details
- 2.8.2 Biomed Lublin Major Business
- 2.8.3 Biomed Lublin Tuberculosis Vaccine Treatment Product and Services
- 2.8.4 Biomed Lublin Tuberculosis Vaccine Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.8.5 Biomed Lublin Recent Developments/Updates
- 2.9 Taj Pharmaceuticals
- 2.9.1 Taj Pharmaceuticals Details
- 2.9.2 Taj Pharmaceuticals Major Business
- 2.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product and Services
- 2.9.4 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.9.5 Taj Pharmaceuticals Recent Developments/Updates
- 2.10 Ataulpho de Paiva
- 2.10.1 Ataulpho de Paiva Details
- 2.10.2 Ataulpho de Paiva Major Business
- 2.10.3 Ataulpho de Paiva Tuberculosis Vaccine Treatment Product and Services
- 2.10.4 Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.10.5 Ataulpho de Paiva Recent Developments/Updates
- 2.11 IVAC
- 2.11.1 IVAC Details
- 2.11.2 IVAC Major Business
- 2.11.3 IVAC Tuberculosis Vaccine Treatment Product and Services
- 2.11.4 IVAC Tuberculosis Vaccine Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.11.5 IVAC Recent Developments/Updates
- 2.12 Queen Saovabha Mem. Inst
- 2.12.1 Queen Saovabha Mem. Inst Details
- 2.12.2 Queen Saovabha Mem. Inst Major Business
- 2.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product and Services
- 2.12.4 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.12.5 Queen Saovabha Mem. Inst Recent Developments/Updates
- 2.13 Microgen
- 2.13.1 Microgen Details
- 2.13.2 Microgen Major Business
- 2.13.3 Microgen Tuberculosis Vaccine Treatment Product and Services
- 2.13.4 Microgen Tuberculosis Vaccine Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.13.5 Microgen Recent Developments/Updates
3 Competitive Environment: Tuberculosis Vaccine Treatment by Manufacturer
- 3.1 Global Tuberculosis Vaccine Treatment Sales Quantity by Manufacturer (2019-2024)
- 3.2 Global Tuberculosis Vaccine Treatment Revenue by Manufacturer (2019-2024)
- 3.3 Global Tuberculosis Vaccine Treatment Average Price by Manufacturer (2019-2024)
- 3.4 Market Share Analysis (2023)
- 3.4.1 Producer Shipments of Tuberculosis Vaccine Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2023
- 3.4.2 Top 3 Tuberculosis Vaccine Treatment Manufacturer Market Share in 2023
- 3.4.3 Top 6 Tuberculosis Vaccine Treatment Manufacturer Market Share in 2023
- 3.5 Tuberculosis Vaccine Treatment Market: Overall Company Footprint Analysis
- 3.5.1 Tuberculosis Vaccine Treatment Market: Region Footprint
- 3.5.2 Tuberculosis Vaccine Treatment Market: Company Product Type Footprint
- 3.5.3 Tuberculosis Vaccine Treatment Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Tuberculosis Vaccine Treatment Market Size by Region
- 4.1.1 Global Tuberculosis Vaccine Treatment Sales Quantity by Region (2019-2030)
- 4.1.2 Global Tuberculosis Vaccine Treatment Consumption Value by Region (2019-2030)
- 4.1.3 Global Tuberculosis Vaccine Treatment Average Price by Region (2019-2030)
- 4.2 North America Tuberculosis Vaccine Treatment Consumption Value (2019-2030)
- 4.3 Europe Tuberculosis Vaccine Treatment Consumption Value (2019-2030)
- 4.4 Asia-Pacific Tuberculosis Vaccine Treatment Consumption Value (2019-2030)
- 4.5 South America Tuberculosis Vaccine Treatment Consumption Value (2019-2030)
- 4.6 Middle East & Africa Tuberculosis Vaccine Treatment Consumption Value (2019-2030)
5 Market Segment by Type
- 5.1 Global Tuberculosis Vaccine Treatment Sales Quantity by Type (2019-2030)
- 5.2 Global Tuberculosis Vaccine Treatment Consumption Value by Type (2019-2030)
- 5.3 Global Tuberculosis Vaccine Treatment Average Price by Type (2019-2030)
6 Market Segment by Application
- 6.1 Global Tuberculosis Vaccine Treatment Sales Quantity by Application (2019-2030)
- 6.2 Global Tuberculosis Vaccine Treatment Consumption Value by Application (2019-2030)
- 6.3 Global Tuberculosis Vaccine Treatment Average Price by Application (2019-2030)
7 North America
- 7.1 North America Tuberculosis Vaccine Treatment Sales Quantity by Type (2019-2030)
- 7.2 North America Tuberculosis Vaccine Treatment Sales Quantity by Application (2019-2030)
- 7.3 North America Tuberculosis Vaccine Treatment Market Size by Country
- 7.3.1 North America Tuberculosis Vaccine Treatment Sales Quantity by Country (2019-2030)
- 7.3.2 North America Tuberculosis Vaccine Treatment Consumption Value by Country (2019-2030)
- 7.3.3 United States Market Size and Forecast (2019-2030)
- 7.3.4 Canada Market Size and Forecast (2019-2030)
- 7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
- 8.1 Europe Tuberculosis Vaccine Treatment Sales Quantity by Type (2019-2030)
- 8.2 Europe Tuberculosis Vaccine Treatment Sales Quantity by Application (2019-2030)
- 8.3 Europe Tuberculosis Vaccine Treatment Market Size by Country
- 8.3.1 Europe Tuberculosis Vaccine Treatment Sales Quantity by Country (2019-2030)
- 8.3.2 Europe Tuberculosis Vaccine Treatment Consumption Value by Country (2019-2030)
- 8.3.3 Germany Market Size and Forecast (2019-2030)
- 8.3.4 France Market Size and Forecast (2019-2030)
- 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
- 8.3.6 Russia Market Size and Forecast (2019-2030)
- 8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
- 9.1 Asia-Pacific Tuberculosis Vaccine Treatment Sales Quantity by Type (2019-2030)
- 9.2 Asia-Pacific Tuberculosis Vaccine Treatment Sales Quantity by Application (2019-2030)
- 9.3 Asia-Pacific Tuberculosis Vaccine Treatment Market Size by Region
- 9.3.1 Asia-Pacific Tuberculosis Vaccine Treatment Sales Quantity by Region (2019-2030)
- 9.3.2 Asia-Pacific Tuberculosis Vaccine Treatment Consumption Value by Region (2019-2030)
- 9.3.3 China Market Size and Forecast (2019-2030)
- 9.3.4 Japan Market Size and Forecast (2019-2030)
- 9.3.5 South Korea Market Size and Forecast (2019-2030)
- 9.3.6 India Market Size and Forecast (2019-2030)
- 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
- 9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
- 10.1 South America Tuberculosis Vaccine Treatment Sales Quantity by Type (2019-2030)
- 10.2 South America Tuberculosis Vaccine Treatment Sales Quantity by Application (2019-2030)
- 10.3 South America Tuberculosis Vaccine Treatment Market Size by Country
- 10.3.1 South America Tuberculosis Vaccine Treatment Sales Quantity by Country (2019-2030)
- 10.3.2 South America Tuberculosis Vaccine Treatment Consumption Value by Country (2019-2030)
- 10.3.3 Brazil Market Size and Forecast (2019-2030)
- 10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
- 11.1 Middle East & Africa Tuberculosis Vaccine Treatment Sales Quantity by Type (2019-2030)
- 11.2 Middle East & Africa Tuberculosis Vaccine Treatment Sales Quantity by Application (2019-2030)
- 11.3 Middle East & Africa Tuberculosis Vaccine Treatment Market Size by Country
- 11.3.1 Middle East & Africa Tuberculosis Vaccine Treatment Sales Quantity by Country (2019-2030)
- 11.3.2 Middle East & Africa Tuberculosis Vaccine Treatment Consumption Value by Country (2019-2030)
- 11.3.3 Turkey Market Size and Forecast (2019-2030)
- 11.3.4 Egypt Market Size and Forecast (2019-2030)
- 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
- 11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
- 12.1 Tuberculosis Vaccine Treatment Market Drivers
- 12.2 Tuberculosis Vaccine Treatment Market Restraints
- 12.3 Tuberculosis Vaccine Treatment Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Tuberculosis Vaccine Treatment and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Tuberculosis Vaccine Treatment
- 13.3 Tuberculosis Vaccine Treatment Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Tuberculosis Vaccine Treatment Typical Distributors
- 14.3 Tuberculosis Vaccine Treatment Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Tuberculosis Vaccine Treatment. Industry analysis & Market Report on Tuberculosis Vaccine Treatment is a syndicated market report, published as Global Tuberculosis Vaccine Treatment Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Tuberculosis Vaccine Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
